Harrow (HROW) Gross Margin Growth (3y) (2016 - 2026)
Harrow (HROW) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | 115.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 115.00 |
| Mar 31, 2026 | -713.00 |
| Dec 31, 2025 | 960.00 |
| Sep 30, 2025 | 472.00 |
| Jun 30, 2025 | 255.00 |
| Mar 31, 2025 | -550.00 |
| Dec 31, 2024 | 401.00 |
| Sep 30, 2024 | 204.00 |
| Jun 30, 2024 | -126.00 |
| Mar 31, 2024 | -610.00 |
| Dec 31, 2023 | -411.00 |
| Sep 30, 2023 | -371.00 |
| Jun 30, 2023 | 987.00 |
| Mar 31, 2023 | -100.00 |
| Dec 31, 2022 | -204.00 |
| Sep 30, 2022 | 239.00 |
| Jun 30, 2022 | 1,064.00 |
| Mar 31, 2022 | 476.00 |
| Dec 31, 2021 | 1,087.00 |
| Sep 30, 2021 | 1,259.00 |